LUCD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lucid Diagnostics Inc. (LUCD) is not a strong buy at this moment for a beginner investor with a long-term strategy. While there is potential for growth in the future, the current financial performance, lack of significant trading signals, and neutral sentiment from hedge funds and insiders suggest waiting for more favorable conditions or clearer signals before investing.
The technical indicators show a bullish moving average (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (0.0209), indicating a potential upward trend. However, the RSI at 79.665 is in the neutral zone, providing no clear signal. The stock is trading near its R1 resistance level of 1.474 in pre-market, suggesting limited immediate upside potential.
Technical indicators show a bullish moving average trend.
The company's Q3 financials show declining net income (-15.96% YoY), EPS (-60.00% YoY), and gross margin (-7.31% YoY). There is no significant hedge fund or insider trading activity, and there are no recent Congress trading data or influential figure transactions.
In Q3 2025, revenue increased by 3.33% YoY to $1,211,000, but net income dropped by 15.96% YoY to -$10,397,000. EPS decreased by 60.00% YoY to -0.1, and gross margin fell by 7.31% YoY to -48.8%. Overall, the financial performance reflects challenges in profitability and efficiency.
Analyst Edward Woo from Ascendiant maintains a Buy rating and raised the price target to $8.25 from $8, citing expected high growth and Medicare coverage in 2026. This reflects optimism for long-term growth but does not address immediate concerns.
